Midyear 2026 recap: Major clinical findings in optometry

Published on July 10, 2026
A midyear look at 2026's biggest optometry findings, from myopia control research to safety signals on red light therapy and semaglutide.
Continue reading on website
Other news

Fielmann Group Releases Preliminary Second Quarter Results, Highlights International Sales Growth, Store Expansion

July 10, 2026
HAMBURG, Germany—Global eyewear provider Fielmann Group announced preliminary consolidated sales of €1.25 billion for the first half of 2026, marking a 2 percent year-over-year increase from €1.23 billion for the first half of 2025. This growth was supported by a modest expansion in Fielmann Germany and a significant acceleration in international sales, which jumped from 1 percent growth in Q1 to

Nicotinamide Supplementation Associated with Reduced Risk of POAG in Those with OHT

July 10, 2026
Systemic nicotinamide may serve as a prophylactic therapy to delay or prevent the onset of POAG, but many questions on clinical guidance still remain. Photo: Bisant Labib, OD. Click image to enlarge. While traditional management of patients with ocular hypertension relies strictly on lowering intraocular pressure (IOP) to delay primary open-angle glaucoma (POAG) onset, a con